Ophorst Olga J A E, Radosević Katarina, Ouwehand Krista, van Beem Wouter, Mintardjo Ratna, Sijtsma Jeroen, Kaspers Jorn, Companjen Arjen, Holterman Lennart, Goudsmit Jaap, Havenga Menzo J E
Crucell Holland BV, P.O. Box 2048, Leiden 2301 CA, The Netherlands.
Vaccine. 2007 Feb 9;25(8):1426-36. doi: 10.1016/j.vaccine.2006.10.050. Epub 2006 Nov 7.
Previous studies have shown that the immunogenicity of rodent malaria parasite-derived circumsporozoite protein (CS) can be improved by deleting the glycosyl-phosphatidyl-inositol (GPI) signal sequence. To study whether GPI signal sequence deletion would also improve immunogenicity of CS derived from the major plasmodium species causing mortality in humans (P. falciparum), we tested different variants of the P. falciparum CS protein in the context of a live vector-based vaccine carrier (rAd35). We demonstrate that deletion of the GPI signal sequence from CS did not result in altered expression or secretion. In contrast, cellular localization was clearly altered, which perhaps helps to explain the significant improvement of anti-CS antibody and T-cell responses observed in mice using deletion variants in the context of the rAd35 carrier. Our results show that rational design of antigens is warranted for further development of malaria vaccines.
先前的研究表明,通过删除糖基磷脂酰肌醇(GPI)信号序列,啮齿动物疟原虫来源的环子孢子蛋白(CS)的免疫原性可以得到改善。为了研究删除GPI信号序列是否也能提高源自导致人类死亡的主要疟原虫物种(恶性疟原虫)的CS的免疫原性,我们在基于活载体的疫苗载体(rAd35)背景下测试了恶性疟原虫CS蛋白的不同变体。我们证明,从CS中删除GPI信号序列不会导致表达或分泌的改变。相反,细胞定位明显改变,这或许有助于解释在rAd35载体背景下使用缺失变体的小鼠中观察到的抗CS抗体和T细胞反应的显著改善。我们的结果表明,合理设计抗原对于疟疾疫苗的进一步开发是必要的。